Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: River Global Investors LLP 213800HIGHFCAY9K8Z97 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and bene...

NEW YORK--(BUSINESS WIRE)--  15th December 2025 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 12th December 2025 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Santander US Capital Markets LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest pri...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Marathon Asset Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must...

ATHENS, Greece--(BUSINESS WIRE)--GENESIS Pharma partners with Otsuka Pharmaceutical Europe Ltd. to commercialize donidalorsen for hereditary angioedema in Central & Eastern Europe....

LONDON--(BUSINESS WIRE)--FinQuery Accelerates Momentum With 19th Consecutive Quarter as the Top-Ranked Lease Accounting Software...

BALLERUP, Denmark--(BUSINESS WIRE)--NOT FOR UK USE – NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today announced submission of a label expansion application to the European Medicines Agency (EMA) to expand the use of Anzupgo® (delgocitinib) cream to adolescents aged 12 to 17 years, living with moderate to severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or inappropriate in the European Union. The label expansion application h...

PARIS--(BUSINESS WIRE)--Palantir Technologies Inc. (NASDAQ: PLTR) announces a three-year renewal of its contract with the DGSI, France's domestic intelligence agency, extending a partnership that has been ongoing for nearly a decade. This agreement relates to the supply of Palantir’s proprietary software platform, as well as the integration, support, and assistance services that are necessary for the software’s deployment and operational use. This renewal comes at a time when national security...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 12/12/2025 Issue ¦ Delamare Cards MTN Issuer plc - Series 2023-1 Class A1 GBP 300,000,000 FRN due April 2031     ISIN Number ¦ XS2607547341 ISIN Reference ¦ 260754734 Issue Nomin GBP ¦ 300000000 Period ¦ 11/19/2025 to 12/19/2025   Payment Date 12/19/2025 Number of Days ¦ 30 Rate ¦ 4.7768   Denomination GBP ¦ 1000   ¦ 300000000   ¦       Amount Payable per Denomination ¦ 3.93   ¦ 1177841.1   ¦      ...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 12 December 2025 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 12 December 2025 Number of Public Shares Purchased:...

LONDON--(BUSINESS WIRE)--  15 December 2025 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 12 December 2025, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Peel Hunt LLP (“Peel H...